Back
Syros Pharmaceuticals, Inc. 10K Form
Sell
17
SYRS
Syros Pharmaceuticals, Inc.
Last Price:
$0.0000
Seasonality Move:
8.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SYRS News And Ratings
See the #1 stock for the next 7 days that we like better than SYRS
SYRS Financial Statistics
Sales & Book Value
| Annual Sales: | $9.9M |
|---|---|
| Cash Flow: | $-20.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.41 |
| Price / Book: | 9.66 |
Profitability
| EPS (TTM): | -3.07000 |
|---|---|
| Net Income (TTM): | $-97.8M |
| Gross Margin: | $7.7M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Syros Pharmaceuticals, Inc. Earnings Forecast
Key Syros Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for SYRS is 77.33%.
-
The Selling, General & Administrative Expenses for SYRS have been equal to 284.64% of Gross Profit Margin.
-
The Research & Development expenses have been 1,065.83% of Revenue.
-
The Net Earning history of SYRS is -1,656.34% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 7 years.
Syros Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SYRS |
| CUSIP: | 87184Q |
| Website: | syros.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SYRS Technical Analysis vs Fundamental Analysis
Sell
17
Syros Pharmaceuticals, Inc. (SYRS)
is a Sell
Is Syros Pharmaceuticals, Inc. a Buy or a Sell?
-
Syros Pharmaceuticals, Inc. stock is rated a SellThe current Syros Pharmaceuticals, Inc. [SYRS] share price is $0.0005. The Score for SYRS is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.